Table of Contents
Overview
New York, NY – September 26, 2025 – The Global Nattokinase Market is projected to reach USD 68.4 million by 2034, rising from USD 38.9 million in 2024, with a CAGR of 5.8% between 2025 and 2034. North America continues to dominate this space, accounting for 45.2% of the market in 2024, valued at USD 17.6 million.
Nattokinase is a natural enzyme derived from natto, a traditional Japanese food made by fermenting soybeans with Bacillus subtilis. Known for its cardiovascular support benefits, nattokinase helps break down fibrin, a protein linked to blood clot formation, thereby promoting healthy circulation and heart function.
The market is expanding as consumer interest in preventive healthcare and natural remedies grows. Demand for functional foods, dietary supplements, and nutraceuticals featuring this enzyme is on the rise, particularly as people turn toward plant-based and traditional solutions. Recent funding activities highlight this momentum. Zeus Hygia, a nutraceutical ingredient start-up, secured $2.5 million in funding to strengthen innovation.
Similarly, a stick-on supplement brand attracted ₹50 lakhs in investment on Shark Tank India, while gut-health driven company The Good Bug raised ₹100 crore. Additionally, HealthKart boosted its market position with $153 million in funding from ChrysCapital and Motilal Oswal Alternates. The primary growth driver remains the rising burden of cardiovascular diseases, which the World Health Organization identifies as the leading global cause of death. This creates strong demand for natural, safer alternatives like nattokinase.
Alongside, the wider adoption of functional foods that combine nutrition with therapeutic benefits is opening new opportunities. Greater awareness, supportive regulatory approvals, and innovation in supplement formulations will shape future growth. Expanding distribution channels and government encouragement for natural health solutions are also expected to accelerate adoption, positioning nattokinase as a key player in the nutraceutical landscape.
Key Takeaways
- The Global Nattokinase Market is expected to be worth around USD 68.4 million by 2034, up from USD 38.9 million in 2024, and is projected to grow at a CAGR of 5.8% from 2025 to 2034.
- In 2024, up to 10000 Fu/g of the nattokinase market by type reached a 44.8% share.
- Nattokinase Market by nutraceuticals application accounted for a 43.2% significant share.
- Offline distribution dominated the nattokinase market channels with a 76.9% share.
- The strong demand in North America, holding 45.2% share, is valued at USD 17.6 Mn.
➤ Curious about the content? Explore a sample copy of this report – https://market.us/report/nattokinase-market/request-sample/
Report Scope
| Report Features | Description |
|---|---|
| Market Value (2024) | USD 38.9 Million |
| Forecast Revenue (2034) | USD 68.4 Million |
| CAGR (2025-2034) | 5.8% |
| Segments Covered | By Type (Up to 10000 Fu/g, 10001-20000 Fu/g, Above 20001 Fu/g), By Application (Nutraceuticals, Food Additives, Pharmaceuticals, Others), By Distribution Channel(Online, Offline) |
| Competitive Landscape | Japan Bio Science Laboratory Co., Ltd., Creative Enzymes, Bioven Ingredients, Eiffel Biotech, Daiwa Pharmaceutical Co., Ltd., Contek Life Science Co., Ltd., NutraCap Labs, Infinita Biotech Private Limited, PHARMANAGER INGREDIENTS, GeneFerm Biotechnology Co., Ltd. |
➤ Directly purchase a copy of the report – https://market.us/purchase-report/?report_id=157259
Key Market Segments
By Type Analysis
The Nattokinase Market in 2024 saw the “up to 10,000 FU/g” segment lead with a 44.8% share. This segment’s dominance reflects consumer preference for a balanced potency that combines affordability and efficacy. Widely used in dietary supplements and functional foods, this enzyme strength suits for daily consumption without dosage concerns, appealing to those embracing preventive healthcare trends.
Its versatility in formulations like capsules, nutraceutical blends, and fortified beverages enhances its popularity. Targeting a broad demographic, particularly older adults seeking plant-based cardiovascular support, this segment is poised to maintain its lead as awareness of natural enzymes grows.
By Application Analysis
Nutraceuticals dominated the Nattokinase Market in 2024, holding a 43.2% share. This segment’s strength stems from the rising demand for natural bioactive compounds supporting cardiovascular health and blood flow. Nattokinase’s integration into capsules, tablets, and powders aligns with consumer preferences for convenient, lifestyle-friendly supplements.
The segment benefits from increased accessibility through pharmacies, online platforms, and health food stores, driven by the growing trend of proactive health management. As consumers favor natural alternatives over synthetic options, nutraceuticals remain the primary channel for Nattokinase consumption.
By Distribution Channel Analysis
Offline channels led the Nattokinase Market in 2024 with a 76.9% share, showcasing strong consumer trust in physical retail like pharmacies, health food stores, and specialty shops. These outlets offer a tangible purchasing experience, with expert consultations fostering confidence, especially among first-time buyers.
The offline channel’s credibility is bolstered by established networks, in-store promotions, and bundled offers. In regions with limited internet access or a preference for traditional shopping, offline sales remain dominant for healthcare-related products like Nattokinase.
Regional Analysis
North America led the global Nattokinase Market in 2024, capturing a 45.2% share valued at USD 17.6 million. This dominance is driven by a robust nutraceutical industry, high cardiovascular disease prevalence, and growing consumer awareness of preventive healthcare. Demand for plant-based supplements, supported by North America’s advanced healthcare infrastructure and informed population, fuels Nattokinase’s popularity.
Widespread availability through offline and online channels further strengthens the region’s position. While Europe, Asia Pacific, the Middle East & Africa, and Latin America show growing interest, North America’s market leadership shapes global trends and long-term opportunities for Nattokinase.
Top Use Cases
- Cardiovascular Support: Nattokinase acts as a natural helper for heart health by gently thinning blood and easing flow through veins. People facing daily stress or a family history of heart issues turn to it for steady support. As a market analyst, I see rising interest in such gentle, plant-based options amid growing wellness trends, making it a smart pick for preventive routines that fit busy lifestyles without harsh side effects.
- Blood Clot Prevention: This enzyme shines in breaking down sticky bits in blood that can form clots, lowering risks for sudden blockages. Travelers on long flights or those with desk-bound jobs use it to stay safe during low-movement times. From a market view, its appeal grows with more folks seeking easy defenses against travel woes, boosting demand in portable supplement formats for on-the-go protection.
- Blood Pressure Management: Nattokinase helps calm high pressure by relaxing vessel walls and improving circulation, offering a soothing aid for tense days. Those with mild ups and downs in readings find it a calm companion. Analysts like me note its fit in the booming natural calm category, where consumers favor subtle, daily helpers over quick fixes for lasting vessel wellness.
- Stroke Risk Reduction: By keeping blood smooth and clots at bay, nattokinase serves as a quiet guardian against brain flow interruptions. Older adults or those with warning signs embrace it for peace of mind. In market scans, this positions it strongly in aging gracefully segments, where proactive brain-heart links draw savvy buyers to enzyme-driven shields for sharper, safer years.
- Brain Health Boost: Nattokinase may clear foggy buildup in the mind, supporting clear thinking and memory as years add up. Creative pros or lifelong learners add it to sharpen focus without jitters. As an analyst, I spot its edge in cognitive care markets, riding waves of interest in natural clarity aids that link heart flow to headspace for vibrant, everyday vitality.
Recent Developments
1. Japan Bio Science Laboratory Co., Ltd.
Japan Bio Science Laboratory continues to lead in nattokinase research, focusing on clinical validation for cardiovascular health. A key recent development is the substantiation of their flagship ingredient, NSK-SD, for supporting healthy blood flow and reducing arterial stiffness. They actively promote new clinical data to expand health claims in international markets, reinforcing NSK-SD’s position as a scientifically-backed, high-purity nattokinase standard for dietary supplements.
2. Creative Enzymes
Creative Enzymes has expanded its portfolio beyond research-grade enzymes to include high-purity nattokinase for the supplement and pharmaceutical industries. A recent focus is offering nattokinase in various activity strengths and formulations, including bulk powders for B2B clients. They emphasize rigorous quality control, analytical services, and custom fermentation processes to meet specific client requirements, positioning themselves as a reliable supplier for scale-up manufacturing.
3. Bioven Ingredients
Bioven Ingredients markets its nattokinase ingredient, Nattozyme, with a strong emphasis on scientific support. A significant recent development is the promotion of new clinical studies investigating Nattozyme’s benefits for fibrinolytic activity and circulation. They are actively targeting the global nutraceutical market by providing comprehensive technical dossiers and marketing collateral to help brands formulate effective cardiovascular health supplements with a proven ingredient.
4. Eiffel Biotech
Eiffel Biotech specializes in the fermentation and production of pharmaceutical-grade enzymes. Their recent work on nattokinase involves optimizing production strains and downstream processing to achieve exceptionally high purity and specific activity levels suitable for more advanced pharmaceutical applications. They focus on providing a consistent, well-documented nattokinase product that meets the stringent requirements for clinical research and potential drug development.
5. Daiwa Pharmaceutical Co. Ltd.
Daiwa Pharmaceutical, a pioneer in nattokinase commercialization, continues to highlight the extensive research behind its ingredient. Recent developments involve promoting long-term consumer safety data and new meta-analyses that consolidate evidence for nattokinase’s benefits. They focus on educating the market about the history and efficacy of their original nattokinase formulation, aiming to differentiate it from newer entrants and maintain their established reputation.
Conclusion
Nattokinase stands out as a gentle powerhouse from ancient fermented soybeans, weaving into modern lives as a trusted ally for smoother blood flow and heart harmony. Its natural touch appeals to health seekers craving simple, effective ways to nurture vessels and vitality without fuss. In this evolving wellness landscape, it promises steady growth as a go-to for preventive care, blending tradition with today’s call for clean, supportive routines that foster longer, lighter living.
Discuss Your Needs With Our Analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
